Remove Ethics Remove Patients Remove Pharmaceutical Remove Safety
article thumbnail

From Classroom to Virtual Reality: How Pharmaceutical Rep Training Has Evolved

Contrarian Sales Techniques

When I first started as a pharmaceutical sales rep a decade ago, training was a rigorous but straightforward affair. We were the bridge between the pharmaceutical companies and the healthcare providers, and our credibility depended on our knowledge and communication skills.

article thumbnail

Staying abreast of regulations with NGS?based viral safety for faster, safer and more ethical lot release of our vaccines

European Pharmaceutical Review

How does that impact the safety of the biologics? Safety is key to the development of any medicine, but the safety considerations linked to bioproduction are more complex because biologics are more sophisticated medicines than small molecules. How are regulatory guidelines adapting to this trend? References.

Ethics 81
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Use of Big Data in Pharmaceutical Marketing: Opportunities and Challenges

Pharma Marketing Network

Big data has become an increasingly important tool for businesses across various industries, and the pharmaceutical industry is no exception. However, the use of big data in pharmaceutical marketing also poses significant challenges that must be considered. One of the biggest challenges is ensuring that patient privacy is protected.

article thumbnail

MHRA regulation overhaul: new scheme for lowest-risk UK clinical trials

European Pharmaceutical Review

This will be the case if the trial sponsor can demonstrate the trial meets the MHRA’s criteria, such as safety issues of the investigational medicine. An opinion from a research ethics committee will remain a requirement for eligible trials, the agency added. Clinical trial amendment applications will not be eligible.

Ethics 90
article thumbnail

The Use of Big Data in Pharmaceutical Marketing: Opportunities and Challenges

Pharma Marketing Network

Big data has become an increasingly important tool for businesses across various industries, and the pharmaceutical industry is no exception. However, the use of big data in pharmaceutical marketing also poses significant challenges that must be considered. One of the biggest challenges is ensuring that patient privacy is protected.

article thumbnail

How clinical outcome assessments can help us understand the patient experience

Clarivate

Clinical outcome assessments can take years to generate but may pay big dividends in patient-focused drug development, centering the patient experience and potentially bolstering a product’s case with regulators and payers. A clinical outcome assessment is a measure that describes or reflects how a patient feels, functions or survives.

article thumbnail

Data integrity considerations in Pharma and Life Sciences

European Pharmaceutical Review

In the pharmaceutical/life sciences industries, maintaining data integrity is crucial given its role in making critical decisions that shape outcomes from drug development to human health. What is the biggest impact of having compromised data when working with regulatory bodies in the pharmaceutical industry? How can this be mitigated?